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ABSTRACT
Many types of eyelid tumors may easily be diagnosed from a clinical point 
of view. However only a small number of large studies exist exploring 
the frequency of eyelid lesions from different regions. According to the 
epidemiology of various eyelid lesions happened in Yogyakarta Special 
Region, this study was aimed to investigate the prevalence of eyelid tumors in 
Yogyakarta Special Region. A total of 94 patients were enrolled in a descriptive 
study. The data were taken retrospectively from the medical record. All 
patients were diagnosed with eyelid tumors from January 2014 until December 
2017 by histopathological examination. Among the subjects, 56 (59.6%) were 
male and 38 (40.4%) were female. There was no difference found in laterality 
(OD 46% vs OS 50%). Sebaceous carcinoma was found in 15 (16%) patients, 
followed by squamous cell carcinoma (SCC) 13 (13.8%), basal cell carcinoma 
(BCC) 11 (11.7%), epidermoid cyst 7 (7.4%), non-Hodgkin lymphoma 7 (7.4%), 
and others. We also found that 11 (11.7%) of patients showed an inflammation 
appearance only. The therapy was varied from extirpation and biopsy (39.4%), 
wide excision (27.7%), excision and biopsy (18.1%), exenteration (10.6%), and 
also anterior and lateral orbitotomy (2.1%) for each procedure. The eyelid 
tumor was found equally in the right and the left eye. Sebaceous carcinoma 
followed by SCC and BCC were the most common eyelid tumor found in this 
study. A further study is needed to determine the risk factor of each tumor.
ABSTRAK
Banyak jenis tumor kelopak mata dapat dengan mudah didiagnosis dari 
sudut pandang klinis, hanya sedikit penelitian yang mengeksplorasi frekuensi 
lesi kelopak mata dari berbagai tempat. Berdasarkan kejadian epidemiologi 
mengenai lesi kelopak mata di Daerah Istimewa Yogyakarta, penelitian ini 
bertujuan untuk menyelidiki prevalensi tumor kelopak mata di Daerah 
Istimewa Yogyakarta. Sebanyak 94 pasien terdaftar dalam penelitian deskriptif. 
Data diambil secara retrospektif dari rekam medis. Semua pasien didiagnosis 
dengan tumor kelopak mata dari Januari 2014 hingga Desember 2017 dengan 
pemeriksaan histopatologis. Di antara subyek, 56 (59,6%) adalah laki-laki dan 
38 (40,4%) adalah perempuan. Tidak ada perbedaan yang ditemukan dalam 
lateralitas (OD 46% vs OS 50%). Karsinoma sebasea ditemukan pada 15 (16%) 
pasien, diikuti oleh karsinoma sel skuamosa (SCC) 13 (13,8%), karsinoma 
sel basal (BCC) 11 (11,7%), kista epidermoid 7 (7,4%), limfoma non-Hodgkin 
7 (7,4%), dan lainnya. Kami juga menemukan bahwa 11 (11,7%) pasien 
menunjukkan penampilan inflamasi saja. Terapi ini bervariasi dari ekstirpasi 
dan biopsi (39,4%), eksisi luas (27,7%), eksisi dan biopsi (18,1%), exenterasi 
(10,6%), dan juga orbitotomi anterior dan lateral (2,1%) untuk setiap prosedur. 
Tumor kelopak mata ditemukan sama di mata kanan dan kiri. Karsinoma 
sebaceous diikuti oleh SCC dan BCC adalah tumor kelopak mata yang paling 
umum ditemukan dalam penelitian ini. Diperlukan penelitian lebih lanjut 
untuk menentukan faktor risiko masing-masing tumor.
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INTRODUCTION
Eyelid tumors are commonly 
diagnosed neoplasms in routine 
ophthalmology practices.1 Benign and 
malignant tumors can arise from each of 
the eyelid layers. Some malignant tumors 
may mimic benign neoplastic and, 
inflammatory conditions and cause late 
diagnosis.2 A wide variety of benign and 
malignant tumors can originate because 
of the existence of many different tissue 
types in the eyelids.3 Different cell types 
of epidermis, Meibomian, Zeiss, Moll, 
Wolfring and Krause glands, eyelash 
follicles may all cause eyelid tumors. 
Eyelid lesions represent 15% of face 
tumors and 5-10% from all cutaneous 
tumors.3,4 The highest incidence of 
eyelids tumor was reported after age of 
60, and most of tumors were situated in 
the lower eyelid and internal canthus.5,6
The global distribution of eyelid 
swellings vary remarkably and their 
incidence appear to be increasing. 
Eyelid lesions can be non-neoplastic or 
neoplastic. Most of them are benign in 
nature; but some are malignant and are 
quite similar to skin cancers.7 Among skin 
cancers, 90% were arise in the head and 
neck region and 10% of them are located 
at eyelid level. Basal cell carcinoma 
is the most common malignant eyelid 
tumor in western countries, whereas in 
Asia, the frequency of sebaceous gland 
carcinoma and squamous cell carcinoma 
are relatively high when compared to 
other type of tumor.8 The most prevalent 
benign lesions in most studies were 
dermoid cysts, nevi, epidermal cysts and 
papilloma.9-11
Although many types of eyelid 
tumors may easily be diagnosed from 
a clinical point of view, some should be 
diagnosed with pathological specimens. 
Only a small number of large studies 
exist exploring the frequency of eyelid 
lesions from different sites of the world.12 
According to the epidemiology of various 
eyelid lesions in our location we can 
improve the availability of appropriate 
treatment strategies in our hospital. To 
date, there is no data about eyelid tumor 
in Yogyakarta Special Region. This study 
was aimed to investigate the prevalence 
of eyelid tumor in one health center as 
tertiary referral hospital in Yogyakarta 
Special Region in Indonesia.
MATERIALS AND METHODS
A total of 94 from 232 patients were 
enrolled in this observational study. The 
data were taken retrospectively from 
medical record in tertiary care referral 
hospitals in Yogyakarta that capable of 
ophthalmic-oncology surgery by trained 
ocular-oncologist (FIGURE 1). All patients 
were diagnosed with eyelid tumor from 
January 2014 until December 2017 by 
histopathological examination. A total 
of 138 patients with ophthalmic lesions 
other than eyelid lesions were excluded 
from the study. We recorded the age, sex, 
tumor location at the eyelid, laterality, 
histopathological diagnosis of the lesions 
and different surgical procedure used in 
the treatment. This study was approved 
by The Medical and Health Research 
Ethics Committee (MHREC), Faculty of 
Medicine, Public Health and Nursing, 
Universitas Gadjah Mada.
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FIGURE 1. Research timetable
RESULTS
Among subjects involved in this 
study, males were found to be more 
affected than females (59.6% vs 40.4%). 
There is no difference in laterality (OD 
45.7% vs OS 54.3%) was found (TABLE 1). 
The highest prevalence of eyelid lesions 
i.e., 18 (19.1%) was observed in the age 
group of 61-70 years, which was followed 
by 17 (18.1%) eyelid lesions in 51-60 years 
of age group. The lowest prevalence of 
eyelid lesions i.e., 4 (4.2%) was in the age 
group less than 11 years. Eyelid lesions 
were more common in upper eyelids 
(60.6%) as compared to the lower eyelids 
(39.4%). We also found that malignant 
lesions were more common than benign 
lesions in eyelid. Benign lesions were 
common in children and adults, whereas 
malignant lesions were common in the 
patients aged 50 years or more.
TABLE 1. Patient’s characteristic
Characteristics Number of cases (%)
Gender
•	 Female 56 (59.6)
•	 Male 38 (40.4)
Age (years)
•	 < 11 4 (4.3)
•	 11 – 20 11 (11.7)
•	 21 – 30 10 (10.6)
•	 31 – 40 6 (6.4)
•	 41 – 50 8 (8.5)
•	 51 – 60 17 (18.1)
•	 61 – 70 18 (19.1)
•	 71 – 80 14 (14.9)
•	 > 80 6 (6.4)
Laterality
•	 Right eye 43 (45.7)
•	 Left eye 51 (54.3)
Tumor location
•	 Upper eyelid 57 (60.6)
•	 Lower eyelid 37 (39.4)
Each decade of age showed 
different pattern of eyelid tumor types. 
The distribution data of tumor types 
according to age were shown (FIGURE 
2). Among all group of age, malignant 
lesions only distribution were shown in 
the > 81 groups of age.
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FIGURE 2. Distribution data of malignancy types and the age
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FIGURE 3. Distribution of malignant lesions
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FIGURE 4. Distribution of benign lesions
Among malignant lesions, the highest 
prevalence was shown in sebaceous 
carcinoma 18 (18.09%) patients, followed 
by squamous cell carcinoma (SCC) 13 
(13.83%), basal cell carcinoma (BCC) 
10 (10.64%), non-hodgkin lymphoma 
7 (7.45%), malignant melanoma 2 
(2.13%) and spindle cell tumor 1 (1.06%) 
(FIGURE 3). In the other hand, the 
highest prevalence in benign eyelid 
lesions were found as an inflammation 
only 15 (15.96%) patients, followed by 
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epidermoid cyst 5 (5.32%), and the lowest 
prevalence were seborrheic keratosis, 
schwannoma, xanthelasma, dermoid 
The location of the eyelid tumor 
was distributed in left upper eyelid 
33 (35.11%), followed by right upper 
eyelid 24 (25.53%), right lower eyelid 
19 (20.21%), and left lower eyelid 18 
(19.15%). The therapy was varied from 
extirpation and biopsy (39.4%), wide 
excision (27.7%), excision and biopsy 
(18.1%), exenteration (10.6%), and also 
anterior and lateral orbitotomy (2.1%) 
for each procedure.
DISCUSSION
The occurrence of malignant 
lesions on this study was found higher 
than benign lesions, and majority was 
presented at the sixth decade of life. This 
probably due to the length of exposure 
to the causal agents or the failure of 
surveillance mechanism from a DNA 
that leads to development of malignant 
lesion. Our study showed a similar result 
to the study of Paul et al. and Coroi et 
al. the most affected age range was the 
sixth decade.5,13 In contrary, the study 
of Anandani et al. showed a different 
result, which found that the prevalence 
of benign lesions of the eyelids was 
higher than malignant lesion.10
This study showed males were found 
to be more affected than females (59.6% 
vs. 40.4%). This result similar to the study 
of Anandani et al. in which males were 
found to be more affected than females 
(57.82% vs. 42.18%).10 Meanwhile, the 
study of Paul et al. showed that females 
were more affected than males (53% 
vs. 47%).13 In this study, left upper 
eyelid (35.11 %) was the most common 
involved region when compared to 
right lower eyelid (20.21%). Other study 
showed varied result and reported 
that the common predilection of eyelid 
tumor was at right upper eyelid, left 
upper eyelid and lower eyelids.5,10,13 This 
result may vary between studies due to 
the type of tumor, risk factor, and race 
variance. In the present study, SCC was 
more common than BCC, unlike others 
in which BCC was more common than 
SCC. A particular study showed that the 
occurrence of BCC is most common in 
lower lid whereas, SCC is more common 
than BCC in upper lid.14 In contrast to 
other study, our previous study showed 
that most of BCC were found in lower 
eyelid.15 Several studies showed that 
the eyelid malignancy incidence was 
increased in patients aged > 50 years. 16-18 
cyst, and chondroid syringoma which 
only found in 1 (1.1%) patient (FIGURE4).
39.4%
27.7%
18.1%
10.6%
2.1%
2.1%
Extirpation and Biopsy
Wide Excision
Excision and Biopsy
Exenteration
Anterior Orbitotomy
Lateral Orbitotomy
Surgical Procedures
FIGURE 4. Distribution of surgical procedure for eyelid tumor
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Concordantly, in our study all malignancy 
was found significantly higher in the in 
patients aged > 50 years.
In the present study, we also 
found that SGC was the most common 
malignancy among all malignant 
tumours. Concordantly, the study of 
Gupta et al. sebaceous gland carcinoma 
was more common in North India as 
compared to BCC and SCC while in the 
studies undertaken by Anandani et al., 
SCC was the commonest one.10,16
CONCLUSION
This study found that the eyelid 
tumor in Yogyakarta Special Region 
was majority found in male patient, 
presented at age of 60-70 years, and 
commonly locatedat superior eyelid. 
Histopathological result showed most 
cases were inflammation for benign 
lesion and sebaceous carcinoma for 
malignant lesion. Extirpation and 
biopsy were the most frequent surgical 
procedure approach found in this study.
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